Samuel A. Silver
Papers
2
Total Citations
15
H-Index
2
About
Dr. Samuel A. Silver is a leading clinician-scientist whose research bridges the critical intersection of nephrology and cognitive neuroscience. His primary focus is on the neurocognitive consequences of kidney disease, particularly how acute kidney injury (AKI) and chronic kidney disease (CKD) impact brain function. Dr. Silver’s major contribution lies in pioneering the use of advanced, robotic technology to detect subtle but quantifiable neurocognitive impairments that standard clinical tests often miss. His landmark 2021 study, which has garnered 12 citations, was the first to demonstrate that survivors of AKI exhibit measurable deficits in executive function and visuospatial processing. Building on this, his 2022 work employed multilevel modeling to characterize the progressive nature of these deficits across the entire spectrum of kidney disease—from AKI to CKD and kidney failure. By revealing that even mild kidney injury can leave a lasting "cognitive footprint," Dr. Silver’s research is reshaping our understanding of patient recovery and long-term quality of life, establishing a new frontier in post-AKI care and rehabilitation.
Research Focus
Key Achievements
Top Papers
- 1
- 2